These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6346960)

  • 21. The impact of neglecting nonlinear plasma-protein binding on disopyramide bioavailability studies.
    Upton RA; Williams RL
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):365-79. PubMed ID: 3772738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma disopyramide concentrations following a 300-mg oral loading dose in acute myocardial infarction.
    Weissberg PL; Matenga J; Hayler AM; Holt DW
    Ther Drug Monit; 1982; 4(3):277-80. PubMed ID: 7135457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical pharmacology of disopyramide].
    Rewerski W; Dorociak A; Walczak F; Dobiasz A
    Pol Tyg Lek; 1980 Jul; 35(29):1109-12. PubMed ID: 7001399
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum drug concentrations and adverse effects in cardiac patients after administration of a new controlled-release disopyramide preparation.
    Zema MJ
    Ther Drug Monit; 1984; 6(2):192-8. PubMed ID: 6740739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the interaction between digoxin and disopyramide.
    Risler T; Burk M; Peters U; Grabensee B; Seipel L
    Clin Pharmacol Ther; 1983 Aug; 34(2):176-80. PubMed ID: 6872411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma binding of disopyramide.
    David BM; Madsen BW; Ilett KF
    Br J Clin Pharmacol; 1980 Jun; 9(6):614-8. PubMed ID: 7387819
    [No Abstract]   [Full Text] [Related]  

  • 27. Disopyramide kinetics in patients with acute myocardial infarction.
    Ilett KF; Madsen BW; Woods JD
    Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic characteristics of a new sustained-release theophylline capsule with a longer absorption profile: single and multiple dosing bioavailability studies.
    Saccar CL; Green LD; Helsel CL; Niehls ME; Diconcetto JA; Mansmann HC; McGeady SJ
    Ann Allergy; 1983 Apr; 50(4):245-8. PubMed ID: 6340563
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of the anticholinergic effects of two formulations of disopyramide in healthy volunteers.
    Longmore J; Berry JL; Szabadi E; Bradshaw CM
    Eur J Clin Pharmacol; 1990; 39(3):305-9. PubMed ID: 2257872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiarrhythmic effect of disopyramid retard versus propranolol retard in ventricular extrasystole].
    Fechter P; Nager F
    Schweiz Med Wochenschr; 1982 Dec; 112(51):1897-900. PubMed ID: 6187065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gas-liquid chromatographic method for the routine estimation of disopyramide in plasma or serum.
    Johnston A; McHaffie D
    J Chromatogr; 1978 May; 152(2):501-6. PubMed ID: 659546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of total and unbound disopyramide: implications for clinical use of the immediate and controlled-release dosage forms.
    Piscitelli DA; Fischer JH; Schoen MD; Hoon TJ; Bauman JL
    J Clin Pharmacol; 1994 Aug; 34(8):823-8. PubMed ID: 7962670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.
    Karim A; Kook C; Novotney RL; Zagarella J; Campion J
    Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence photometric determination of disopyramide and mono-N-dealkylated disopyramide in plasma after separation by thin-layer chromatography.
    Gupta RN; Eng F; Lewis D; Kumana C
    Anal Chem; 1979 Mar; 51(3):455-8. PubMed ID: 532975
    [No Abstract]   [Full Text] [Related]  

  • 35. Prophylactic disopysramide: its clinical effects related to plasma concentration in myocardial infarction.
    Hillson RM; Boyd E; Cunningham J
    J Int Med Res; 1980; 8(5):314-20. PubMed ID: 6998791
    [No Abstract]   [Full Text] [Related]  

  • 36. Disopyramide phosphate: tissue uptake and relationship between drug concentrations in the plasma and myocardium of rats.
    Karim A; Kook C; Campion J; Doherty M
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):222-36. PubMed ID: 921413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disopyramide-dihydrogen phosphate (Rythmodul) in auricular fibrillation].
    Erbersdobler O
    ZFA (Stuttgart); 1978 Dec; 54(34):1765-8. PubMed ID: 362754
    [No Abstract]   [Full Text] [Related]  

  • 38. Disopyramide.
    Aitio ML
    Med J Aust; 1979 Nov; 2(10):550. PubMed ID: 530161
    [No Abstract]   [Full Text] [Related]  

  • 39. [Delayed-action disopyramide in the treatment of hyperkinetic ventricular arrhythmia. A randomized clinical comparative study vs immediate-action disopyramide].
    Romanò M; Spinelli A; Cazzani E; Muzio L
    Clin Ter; 1991 Jul; 138(1):13-9. PubMed ID: 1834395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of blood collection technique on serum and plasma protein binding of disopyramide.
    Haughey DB; Lima JJ
    Eur J Clin Pharmacol; 1982; 22(2):185-9. PubMed ID: 7094989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.